Methadone maintenance and hepatitis C virus infection among injecting drug users.
about
A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugsSelf-reported hepatitis C virus antibody status and risk behavior in young injectorsIncidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infectionHCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, ChinaRisk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment ProgramPrevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatmentPredictors of hepatitis knowledge improvement among methadone maintained clients enrolled in a hepatitis intervention program.The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug usersInfrequent reinfection after successful treatment for hepatitis C virus infection in injection drug usersHepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in ChinaHepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.Substance use and hepatitis C: an ecological momentary assessment study.Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE).How can hepatitis C be prevented in the long term?Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior.Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle areaTrends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow.The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned.Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenanceCritical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users.Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B.Opioids and HIV/HCV infection.The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis C virus among illicit drug users: a modeling study.Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.Evaluation of Methadone Treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS).
P2860
Q24629455-D88BEFF8-C6F7-40B8-89B6-BDB024EABD29Q27478003-3F1D6F6F-342B-48C0-9C84-48458CB2A8DAQ28361460-4831ED37-47AD-45D2-9314-D92F750B3B9CQ28483942-2CBDA63D-9109-433D-99AD-576E65601788Q28542883-BB88BF75-3A58-4F03-9A8E-613C679200FCQ28550339-F931D614-97C7-4761-BF35-F65C4447AD44Q28768135-2B90F037-4ECE-4EEA-8C4B-CE86D4D5F2F7Q33256564-925BA6F5-BCC3-4CC2-8C38-1CF3C9D6C17AQ33636189-A7151091-0ED6-4FED-BE40-5034FA623B16Q34079944-42A53C2E-4803-4DDA-80E8-69F36700A1BEQ34498633-0CE67278-B5FB-4F01-8E93-EA98D7A55AFBQ34795057-D07BD653-7E6E-4303-84F5-DB8D779ED6E9Q35885462-7D13B68A-6CE6-40A9-8BDE-C33CE34FA00DQ35961748-EA33BACB-924E-42B4-8E08-8090EA90B0C3Q36073120-4E79EBF6-7662-4736-997E-503370460CF4Q36137709-AC33A861-4148-40C7-94C7-B5F2C094294AQ36144776-DC452F56-CC90-45A7-BE91-65214960C65DQ36226863-62C7B422-841F-4AC5-AE90-A6A97938F4ECQ36248852-50BA0955-D90B-437D-8681-790AC75C93D7Q36272739-1BFD5CF2-2DF0-4E85-9985-B77B0DC8ED00Q36440948-AF7CF3AE-3FC0-4497-9D02-BFED4FE4F1BBQ36580211-018FEB35-AE62-41EC-9D1D-ACB3D3EB42E4Q36865669-AE12E2DA-C93A-4B66-984E-8E94CB28B070Q37011167-B7F4E6B8-B7D3-40D3-9D5B-0086EC972E5BQ37142229-A799866E-B745-4DC2-B9E5-4C2E08FA3557Q37196683-57733E00-3DE4-430E-BFEE-C188F585E0D0Q37260394-6BE6A4AA-9D90-44D9-ADF8-CBC80F70AC09Q37607856-4F17559B-86A9-46DF-A07C-504920717427Q37663322-7F45CAEC-FCBF-4A16-A915-690A8A170C88Q40048259-0C1F1FCE-A5A2-4104-BB5A-3DEA0FDA2E65Q42720607-FCAC8135-F883-47EC-AD98-3C18206FDF51Q45323809-6CEE2854-5039-4F9D-A513-4760A4E7D3FCQ47578057-7890ADE4-5778-43DF-85ED-48B726ADC808
P2860
Methadone maintenance and hepatitis C virus infection among injecting drug users.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@en
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@nl
type
label
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@en
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@nl
prefLabel
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@en
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@nl
P2093
P1433
P1476
Methadone maintenance and hepatitis C virus infection among injecting drug users.
@en
P2093
P304
P356
10.1046/J.1360-0443.1997.9289999.X
P407
P577
1997-08-01T00:00:00Z